RCG
CELG

Rock Creek Group’s Celgene Corp CELG Stock Holding History

Rock Creek Group’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-5,237
Closed -$494K – 136
2019
Q1 		$494K Buy
+5,237
New +$458K 0.22% 66
2018
Q4 		– Sell
-7,258
Closed -$650K – 108
2018
Q3 		$650K Buy
+7,258
New +$641K 0.27% 70

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Rock Creek Group's CELG Position: Q2 2019 in Review

Rock Creek Group sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 5,237 shares — an estimated $494K sold.

Rock Creek Group first reported a position in CELG in Q3 2018 and held it in 2 quarters. The position peaked at $650K in Q3 2018. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Rock Creek Group reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Rock Creek Group sold 5,237 Celgene Corp shares in Q2 2019, an estimated $494K.
  • Rock Creek Group first reported a position in Celgene Corp in Q3 2018 and held it in 2 quarters.
  • Rock Creek Group's Celgene Corp position peaked at $650K in Q3 2018.
  • 1,287 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Rock Creek Group's 13F filing for Q2 2019, filed 14 Aug 2019.